Financials

  • Market Capitalization 570.08 M
  • Employee 674
  • Founded 2013
  • CEO Thomas Lingelbach
  • Website www.valneva.com
  • Headquarter France
  • FIGI BBG00ZZPBH08
  • Industry 生物技术

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
2817
CAPR
Capricor Therapeutics, Inc. - Common Stock
10.01 USD+1.01%+21.78%+164.81%+58.89%581.97 M USD
2828
SPRY
ARS Pharmaceuticals, Inc. - Common Stock
5.77 USD-3.83%+1.23%+13.58%-37.35%573.81 M USD
2842
PROK
ProKidney Corp. - Class A Ordinary Shares
1.85 USD-2.12%+6.32%+20.13%-11.06%559.30 M USD
2845
CABA
Cabaletta Bio, Inc. - Common Stock
3.30 USD+6.11%+3.12%+23.60%+122.97%559.50 M USD

Valneva SE - American Depositary Shares

Valneva SE 是一家注册于法国圣埃尔布兰的专科疫苗公司,致力于传染病疫苗的研发、生产和商业化。该公司在苏格兰利文斯顿、瑞典索尔纳和奥地利维也纳设有生产基地,并在法国、加拿大和美国设有其他办事处。

新闻